A 35-year-old woman with biopsy-proven SLE (4 years' duration) on hydroxychloroquine and prednisolone 10 mg daily presents with a 3-month history of progressive dyspnea, pleuritic chest pain, and a new pleural effusion on chest X-ray. Pleural fluid analysis shows LE cells present, ANA positive, and low complement. She is afebrile; blood cultures are negative. What is the most appropriate next step in management?
A. Start empirical broad-spectrum antibiotics and antituberculous therapy pending culture results
B. Perform urgent thoracentesis and send fluid for culture, cytology, and TB PCR to exclude infection before treating
C. Increase prednisolone to 0.5–1 mg/kg/day and add azathioprine; repeat imaging in 4 weeks
Refer for pleurodesis given the recurrent nature of SLE-related serositis
D.
Explanation
Clinical Context
This patient has SLE with lupus pleuritis (serositis), evidenced by pleural effusion with LE cells, ANA positivity, and low complement in pleural fluid. She is afebrile with negative blood cultures, making infection unlikely.
Diagnosis of Lupus Pleuritis
Key Point
Serositis (pleuritis, pericarditis, peritonitis) is a common SLE manifestation. Diagnosis is supported by:
Clinical features (pleuritic pain, dyspnea)
Pleural fluid with LE cells or ANA positivity
Low complement in fluid
Exclusion of infection
High-YieldNEET PG
LE cells in pleural fluid are highly specific for lupus serositis and essentially confirm the diagnosis when combined with clinical context.
Management of Lupus Pleuritis
Rationale for Correct Answer
1.
Increase corticosteroids to 0.5–1 mg/kg/day (typically 40–60 mg prednisolone) is the standard first-line therapy for active serositis
2.
Add azathioprine (1–2 mg/kg/day) as a steroid-sparing agent to allow gradual prednisolone taper and reduce relapse risk
3.
Close monitoring with repeat imaging at 4 weeks assesses response
4.
No need for urgent intervention — serositis is not immediately life-threatening and responds well to immunosuppression
Why Thoracentesis Is Not Urgent Here
Clinical Pearl
Thoracentesis was already performed (pleural fluid analysis provided). Repeat thoracentesis is not indicated unless:
Diagnosis remains uncertain
Infection is suspected (fever, positive cultures, clinical deterioration)
Fluid is loculated and causing respiratory compromise
This patient is afebrile with negative cultures — infection is ruled out.
Serositis Management Algorithm
Loading diagram...
Key Point
Serositis typically resolves within 2–4 weeks of corticosteroid escalation. Pleurodesis is reserved for recurrent, refractory effusions unresponsive to medical therapy.
Steroid-Sparing Agents in SLE
Table
Agent
Dose
Onset
Indication
Azathioprine
1–2 mg/kg/day
6–8 weeks
Steroid-sparing, general SLE
Mycophenolate
1–3 g/day
4–6 weeks
Nephritis, steroid-sparing
Cyclophosphamide
500–1000 mg/m² IV monthly
2–4 weeks
Severe/refractory disease
High-YieldNEET PG
Azathioprine is preferred here because serositis alone does not require the intensity of cyclophosphamide, and azathioprine has a good safety profile for long-term use.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
